Spotlight Innovation reveals debt restructuring plan

Spotlight Innovation, a pharmaceutical holding company that acquires rights to proprietary technologies, is restructuring debt through a conversion of promissory notes.

Advertisement

The company said the holders of a series of convertible promissory notes issued between December 2015 and March 2016, totaling $850,000, have agreed to convert the promissory notes into shares of common stock.

“This conversion is a positive step toward simplifying our balance sheet,” Cristopher Grunewald, Spotlight Innovation’s president and CEO, said in a statement. “Debt restructuring allows us to accelerate development of our product candidates, creating value for both current and future shareholders. Moving forward, we will continue to look for debt restructuring opportunities that further our development goals.”

 

More articles on finance:

KentuckyOne Health lays off 3 top executives
55 employers with the best healthy lifestyle initiatives
Board of Allina-run hospital votes to dissolve

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.